(Q39766573)

English

Conditionally replicating adenovirus therapy utilizing bone sialoprotein promoter (Ad-BSP-E1a) in an in vivo study of treating androgen-independent intraosseous prostate cancer

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

Conditionally replicating adenovirus therapy utilizing bone sialoprotein promoter (Ad-BSP-E1a) in an in vivo study of treating androgen-independent intraosseous prostate cancer (English)

1 reference

Europe PubMed Central

14 September 2017

1 reference

based on heuristic

inferred from title

author name string

Yingming Li

1

1 reference

Europe PubMed Central

14 September 2017

Michael Kacka

2

1 reference

Europe PubMed Central

14 September 2017

Melissa Thompson

3

1 reference

Europe PubMed Central

14 September 2017

Jer-Tsong Hsieh

4

1 reference

Europe PubMed Central

14 September 2017

Kenneth S Koeneman

5

1 reference

Europe PubMed Central

14 September 2017

publication date

6 December 2009

1 reference

Europe PubMed Central

14 September 2017

Urologic Oncology

1 reference

Europe PubMed Central

14 September 2017

29

1 reference

Europe PubMed Central

14 September 2017

624-633

1 reference

Europe PubMed Central

14 September 2017

6

1 reference

Europe PubMed Central

14 September 2017

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Osteocalcin-directed gene therapy for prostate-cancer bone metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Phase I dose escalation clinical trial of adenovirus vector carrying osteocalcin promoter-driven herpes simplex virus thymidine kinase in localized and metastatic hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

In situ gene therapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

In situ gene therapy for adenocarcinoma of the prostate: a phase I clinical trial.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Prostate-specific antigen response and systemic T cell activation after in situ gene therapy in prostate cancer patients failing radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Gene therapy for prostate cancer by controlling adenovirus E1a and E4 gene expression with PSES enhancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Targeting prostate cancer with conditionally replicative adenovirus using PSMA enhancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Conditionally replicative adenovirus driven by the human telomerase promoter provides broad-spectrum antitumor activity without liver toxicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

A novel conditionally replicative adenovirus vector targeting telomerase-positive tumor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Elevated activated partial thromboplastin time during administration of first-generation adenoviral vectors for gene therapy for prostate cancer: identification of lupus anticoagulants

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Human osteocalcin and bone sialoprotein mediating osteomimicry of prostate cancer cells: role of cAMP-dependent protein kinase A signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Bone metastatic LNCaP-derivative C4-2B prostate cancer cell line mineralizes in vitro

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Flexible structures of SIBLING proteins, bone sialoprotein, and osteopontin

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Expression of rat bone sialoprotein promoter in transgenic mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Prognostic value of bone sialoprotein expression in clinically localized human prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Ectopic expression of bone sialoprotein in human thyroid cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Neoplastic odontogenic epithelial cells express bone sialoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Conditionally replicating adenovirus-mediated gene therapy in bladder cancer: an orthotopic in vivo model

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Differential expression of angiogenesis associated genes in prostate cancer bone, liver and lymph node metastases

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Molecular therapy with recombinant p53 adenovirus in an androgen-independent, metastatic human prostate cancer model

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Lineage relationship between LNCaP and LNCaP-derived prostate cancer cell lines

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Control of rapid nitric acid decalcification

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Localization of bone sialoprotein (BSP) to Golgi and post-Golgi secretory structures in osteoblasts and to discrete sites in early bone matrix

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Purification and fragmentation of nondenatured bone sialoprotein: evidence for a cryptic, RGD-resistant cell attachment domain

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Cancer gene therapy: hard lessons and new courses

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Osteocalcin is incompletely spliced in non-osseous tissues

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Renal expression of SIBLING proteins and their partner matrix metalloproteinases (MMPs)

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Oncolytic adenovirus CG7870 in combination with radiation demonstrates synergistic enhancements of antitumor efficacy without loss of specificity

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Cotargeting tumor and tumor endothelium effectively inhibits the growth of human prostate cancer in adenovirus-mediated antiangiogenesis and oncolysis combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Small molecule, oligonucleotide-based telomerase template inhibition in combination with cytolytic therapy in an in vitro androgen-independent prostate cancer model

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

Localization of bone sialoprotein (BSP) expression to sites of mineralized tissue formation in fetal rat tissues by in situ hybridization

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2009.08.012

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.UROLONC.2009.08.012

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39766573&oldid=2090097724"